We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Molecular Diagnostics

Image: The Prosigna test provides clinicians and patients with genomic insights to help make more informed breast cancer treatment decisions (Photo courtesy of Veracyte)

Genomic Test Guides Chemotherapy Decisions in Early-Stage Breast Cancer

A new test estimates 10-year distant recurrence and predicts chemotherapy benefit in early HR+ breast cancer to guide treatment. More...
04 Jun 2026
Image: Cancer study findings showed that extensive chromosome loss is more widespread than previously recognized and often linked to harder-to-treat unstable tumors (image credit: Adobe Stock)

Simple Cytogenetic Method Could Improve Classification of ALL Subtypes

Researchers demonstrate evidence of widespread chromosome loss across cancers and a simple method to distinguish similar-looking ALL subtypes. More...
03 Jun 2026
Image: The blood-based assay captures circulating chromatin, cell-free DNA fragments that are largely inaccessible through standard laboratory methods (image credit: Shuttertstock)

Blood-Based Assay Enables Noninvasive Monitoring of Sarcoma Immunotherapy Response

A new cfDNA assay captures immune, stromal and tumor signals to monitor immunotherapy response and resistance in sarcoma More...
03 Jun 2026
Image: Findings showed that TP53 mutations correlate with lung cancer prognosis and may help guide therapy selection(image credit: Adobe Stock)

Tumor Mutation Marker Helps Refine Lung Cancer Prognosis and Guide Therapy Selection

New data show TP53 mutations in lung cancer predict poorer prognosis and guide selection between EGFR therapy and chemotherapy. More...
02 Jun 2026
PATHFINDER 2 Study: Screen Detected Cancers (Photo courtesy of GRAIL)

Multi-Cancer Test Boosts Detection When Added to Standard Screening

PATHFINDER 2 study findings show that GRAIL’s Galleri MCED test increased cancer detection 6.5-fold when added to recommended cancer screening. More...
02 Jun 2026
Image: Findings show that MRD‑guided intervention demonstrated the potential to delay or possibly prevent leukemic relapse (image credit: Shutterstock)

Blood-Based MRD Monitoring Supports Relapse Prevention in Leukemia

New long-term data show MRD-triggered therapy may delay or prevent relapse in MDS and AML. More...
01 Jun 2026
Image: The Decipher Prostate test can guide treatment decisions in metastatic prostate cancer (Photo courtesy of Veracyte)

Genomic Test Predicts Chemotherapy Benefit in Metastatic Prostate Cancer

New data show a genomic test predicts which metastatic prostate cancer patients benefit from triplet therapy. More...
01 Jun 2026
Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Blood-Based Protein Biomarker Solution for Alzheimer's Disease
BG-DTi2000.
Automated Clinical Chemistry Analyzer
Envoy 500+
New
Fully Automated Urinalysis System
DxU 1800 Fully Automated Urinalysis System


Genetic Testing channel of LabMedica brings the latest in molecular genetics, cytogenetics, and epigenetics, and methods from PCR to FISH, and more.
Copyright © 2000-2026 Globetech Media. All rights reserved.